Dynavax Technologies Corporation ($DVAX)
Filing Information
| Accession Number | 0001628280-26-002640 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 20, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
342,000
Total Value
$2,903,240.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & COO | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 20,000 | $6.80 | $136,100.00 | 83,344 | Direct | โ | View Details | |
President & COO | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 94,000 | $10.47 | $984,180.00 | 177,344 | Direct | โ | View Details | |
President & COO | Common Stock | โ | Jan 15, 2026 | Sale | 114,000 | $15.64 | $1,782,960.00 | 63,344 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 20,000 | โ | โ | 146,528 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 85,655 | โ | โ | 0 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 8,345 | โ | โ | 0 | Direct | โ | View Details |